Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $3.86 Million - $4.22 Million
9,463 Added 71.76%
22,650 $9.47 Million
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $231,182 - $276,798
674 Added 5.39%
13,187 $5.37 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $665,538 - $713,321
1,968 Added 18.66%
12,513 $4.35 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $994,824 - $1.11 Million
-3,164 Reduced 23.08%
10,545 $3.71 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $620,273 - $707,589
2,190 Added 19.01%
13,709 $4.32 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $1.28 Million - $1.44 Million
4,488 Added 63.83%
11,519 $3.33 Million
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $102,412 - $114,268
374 Added 5.62%
7,031 $2.04 Million
Q2 2022

Aug 11, 2022

BUY
$234.96 - $292.55 $39,943 - $49,733
170 Added 2.62%
6,657 $1.88 Million
Q1 2022

May 12, 2022

BUY
$221.42 - $260.97 $421,583 - $496,886
1,904 Added 41.54%
6,487 $1.69 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $67,440 - $85,134
381 Added 9.07%
4,583 $1.01 Million
Q3 2021

Nov 16, 2021

BUY
$181.39 - $202.99 $27,571 - $30,854
152 Added 3.75%
4,202 $762,000
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $114,931 - $135,534
613 Added 17.84%
4,050 $817,000
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $10,558 - $12,306
-51 Reduced 1.46%
3,437 $739,000
Q4 2020

Feb 17, 2021

SELL
$207.01 - $276.09 $6,003 - $8,006
-29 Reduced 0.82%
3,488 $824,000
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $121,178 - $143,669
-474 Reduced 11.88%
3,517 $957,000
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $77,790 - $102,051
345 Added 9.46%
3,991 $1.16 Million
Q1 2020

May 08, 2020

BUY
$199.77 - $247.81 $199 - $247
1 Added 0.03%
3,646 $868,000
Q4 2019

Feb 10, 2020

BUY
$166.71 - $223.91 $105,694 - $141,958
634 Added 21.06%
3,645 $800,000
Q3 2019

Nov 06, 2019

BUY
$166.23 - $187.09 $53,359 - $60,055
321 Added 11.93%
3,011 $513,000
Q2 2019

Aug 12, 2019

BUY
$164.61 - $190.37 $70,453 - $81,478
428 Added 18.92%
2,690 $490,000
Q1 2019

May 06, 2019

BUY
$163.73 - $194.7 $122,470 - $145,635
748 Added 49.41%
2,262 $413,000
Q4 2018

Feb 15, 2019

SELL
$151.91 - $192.21 $232,726 - $294,465
-1,532 Reduced 50.3%
1,514 $251,000
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $510,905 - $587,086
3,046 New
3,046 $589,000
Q2 2018

Aug 14, 2018

SELL
$145.72 - $169.96 $266,667 - $311,026
-1,830 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$151.6 - $177.13 $9,702 - $11,336
64 Added 3.62%
1,830 $299,000
Q4 2017

Feb 08, 2018

BUY
$137.28 - $155.55 $41,184 - $46,665
300 Added 20.46%
1,766 $263,000
Q3 2017

Nov 16, 2017

SELL
$148.13 - $162.24 $17,034 - $18,657
-115 Reduced 7.27%
1,466 $222,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,581
1,581 $207,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.